We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-3.29%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$14.7B
AUM Growth
+$1.28B
Cap. Flow
+$2.06B
Cap. Flow %
13.96%
Top 10 Hldgs %
12.95%
Holding
676
New
148
Increased
154
Reduced
125
Closed
204

Top Buys

Rank Stock Value
1
AER icon
AerCap
AER
+$213M
2
ADBE icon
Adobe
ADBE
+$164M
3
ADI icon
Analog Devices
ADI
+$162M
4
PAYC icon
Paycom
PAYC
+$128M
5
CRM icon
Salesforce
CRM
+$116M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$189M
2
NVDA icon
NVIDIA
NVDA
+$169M
3
DLTR icon
Dollar Tree
DLTR
+$148M
4
VRT icon
Vertiv
VRT
+$127M
5
DELL icon
Dell
DELL
+$122M

Sector Composition

Rank Sector Weight
1 Technology 22.19%
2 Consumer Discretionary 15.96%
3 Industrials 14.65%
4 Healthcare 13.59%
5 Financials 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
376
Emerson Electric
EMR
$88.5B
$2.42M 0.02%
+25,075
New +$2.39M
ETSY icon
377
Etsy
ETSY
$7.38B
$2.39M 0.02%
37,013
-77,289
-68% -$6.1M
IMGN
378
DELISTED
Immunogen Inc
IMGN
$2.38M 0.02%
150,000
ENLC
379
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$2.37M 0.02%
194,283
-97,541
-33% -$1.16M
SANM icon
380
Sanmina
SANM
$10.7B
$2.37M 0.02%
+43,675
New +$2.46M
ETNB
381
CALL
DELISTED
89bio
ETNB
$2.32M 0.02%
150,000
ABCL icon
382
AbCellera Biologics
ABCL
$2.85B
$2.31M 0.02%
+501,355
New +$3.05M
SPRB
383
Spruce Biosciences
SPRB
$127M
$2.26M 0.02%
13,333
AMLX icon
384
Amylyx Pharmaceuticals
AMLX
$2.53B
$2.2M 0.01%
120,157
-200,000
-62% -$4.23M
SGMT icon
385
Sagimet Biosciences
SGMT
$591M
$2.11M 0.01%
+240,029
New +$3.2M
CRNX icon
386
Crinetics Pharmaceuticals
CRNX
$8.93B
$2.07M 0.01%
+69,502
New +$1.43M
FIGS icon
387
FIGS
FIGS
$2.39B
$2.06M 0.01%
+350,000
New +$2.33M
BIDU icon
388
Baidu
BIDU
$37.1B
$2M 0.01%
14,900
-80,100
-84% -$11.2M
TMCI icon
389
Treace Medical Concepts
TMCI
$303M
$1.96M 0.01%
+149,366
New +$2.73M
HOOK
390
DELISTED
HOOKIPA Pharma
HOOK
$1.92M 0.01%
310,944
OPRA
391
Opera Ltd
OPRA
$1.79B
$1.9M 0.01%
+168,750
New +$2.82M
COLD icon
392
Americold
COLD
$4.17B
$1.87M 0.01%
61,489
-1,181,165
-95% -$38.2M
GCMG icon
393
GCM Grosvenor
GCMG
$834M
$1.8M 0.01%
231,735
JANX icon
394
Janux Therapeutics
JANX
$1B
$1.76M 0.01%
+175,000
New +$2.02M
HTZ icon
395
Hertz
HTZ
$756M
$1.71M 0.01%
+139,279
New +$2.33M
SLS icon
396
CALL
SELLAS Life Sciences
SLS
$2.17B
$1.64M 0.01%
1,000,000
-275,000
-22% -$434K
SLDB icon
397
Solid Biosciences
SLDB
$918M
$1.63M 0.01%
646,604
MGTX icon
398
MeiraGTx Holdings
MGTX
$1.21B
$1.62M 0.01%
330,182
JOBY icon
399
Joby Aviation
JOBY
$8.71B
$1.61M 0.01%
+250,000
New +$1.97M
TLRY icon
400
Tilray
TLRY
$602M
$1.61M 0.01%
67,362
-99,134
-60% -$2.34M

Similar funds

Alyeska Investment Group's Q3 2023 Portfolio in Review

As of Q3 2023, Alyeska Investment Group held 676 positions worth $14.7B, up 9.5% from $13.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alyeska Investment Group deployed $2.06B of net new capital in Q3 2023, opening 148 new positions and adding to 154 existing holdings. Its largest new stake was Paycom: 419,219 shares worth $109M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was NVIDIA, an estimated $169M trimmed.

  • Alyeska Investment Group's largest Q3 2023 buy was Paycom: 419,219 shares worth $109M.
  • Alyeska Investment Group added most to AerCap in Q3 2023, an estimated $213M increase.
  • Alyeska Investment Group's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $169M.
  • Alyeska Investment Group fully exited Activision Blizzard in Q3 2023, selling an estimated $189M.
  • Alyeska Investment Group's ten largest holdings make up 13% of its $14.7B portfolio in Q3 2023.
  • Alyeska Investment Group opened 148 new positions and closed 204 in Q3 2023.
  • Alyeska Investment Group's portfolio value rose 9.5% quarter-over-quarter to $14.7B.

Based on Alyeska Investment Group's 13F filing for Q3 2023, filed 14 Nov 2023.